News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Baird William D III
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 7,031 shares
@ $5.4865, valued at
$38.6k
|
|
| 08/07/2023 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 6,906 shares
@ $6.1257, valued at
$42.3k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 4,152 shares
@ $16.2325, valued at
$67.4k
|
|
| 07/19/2022 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 4,080 shares
@ $13.8099, valued at
$56.3k
|
|
| 05/23/2022 |
4
| Baird William D III (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.7, valued at
$34k
|
|
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 427 shares
@ $14.78, valued at
$6.3k
|
|
| 01/11/2022 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 896 shares
@ $23.9078, valued at
$21.4k
|
|
| 11/17/2021 |
4
| Baird William D III (CFO) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Acquired 7,384 shares
@ $0
Disposed of 60,000 options to buy
@ $0
Disposed of 20,000 options to buy
@ $0
Disposed of 25,000 options to buy
@ $0 |
|
| 11/16/2021 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 2,461 shares
@ $0
Granted 8,049 shares
@ $0
Granted 21,628 shares
@ $0
Granted 21,627 shares
@ $0
Granted 19,690 options to buy
@ $243.27, valued at
$4.8M
Granted 6,563 options to buy
@ $114.67, valued at
$752.6k
Granted 16,098 options to buy
@ $44.17, valued at
$711k
|
|
| 08/04/2021 |
4
| Baird William D III (CFO) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 33,585 shares
@ $0
Granted 33,584 shares
@ $0 |
|
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Baird William D III (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 11,000 options to buy
@ $4.2, valued at
$46.2k
|
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2019 |
4
| Baird William D III (CFO) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 60,000 options to buy
@ $156.66, valued at
$9.4M
|
|
| 10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2018 |
4
| Baird William D III (CFO) has filed a Form 4 on AMICUS THERAPEUTICS INC|
Txns:
| Sold 10,000 shares
@ $15.6292, valued at
$156.3k
Exercised 10,000 options to buy
@ $2.45, valued at
$24.5k
|
|
| 04/04/2018 |
4
| Baird William D III (CFO) has filed a Form 4 on AMICUS THERAPEUTICS INC|
Txns:
| Sold 10,000 shares
@ $14.2648, valued at
$142.6k
Exercised 10,000 options to buy
@ $2.45, valued at
$24.5k
|
|
| 01/05/2018 |
4
| Baird William D III (CFO) has filed a Form 4 on AMICUS THERAPEUTICS INC|
Txns:
| Granted 29,803 shares
@ $0
Paid exercise price by delivering 7,302 shares
@ $15.67, valued at
$114.4k
Granted 43,075 options to buy
@ $15.67, valued at
$675k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/22/2016 |
4
| Baird William D III (CFO) has filed a Form 4 on AMICUS THERAPEUTICS INC|
Txns:
| Exercised 3,500 shares
@ $8, valued at
$28k
Sold 3,500 shares
@ $8, valued at
$28k
Sold 17,000 shares
@ $8.0044, valued at
$136.1k
Exercised 3,500 options to buy
@ $2.45, valued at
$8.6k
|
|
| 06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2016 |
4
| Baird William D III (CFO) has filed a Form 4 on AMICUS THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 18,625 shares
@ $9.03, valued at
$168.2k
Paid exercise price by delivering 18,625 shares
@ $9.03, valued at
$168.2k
Exercised 50,000 restricted stock units
@ $0
Exercised 50,000 restricted stock units
@ $0
Granted 90,000 options to buy
@ $9.03, valued at
$812.7k
Granted 90,000 options to buy
@ $9.03, valued at
$812.7k
|
|
|
|
|